Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NAI-107

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Lantibiotics are ribosomally synthesized and post-translationally modified antimicrobial peptides containing thioether rings. In… Expand
  • table 1
2016
2016
Class I lantibiotic dehydratases dehydrate selected Ser/Thr residues of a precursor peptide. Recent studies demonstrated the… Expand
2016
2016
The investigation of self-resistance in antibiotic producers is important to understand the emergence of antibiotic resistance in… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2016
2016
ABSTRACT We used the fruit fly Drosophila melanogaster as a cost-effective in vivo model to evaluate the efficacy of novel… Expand
2015
2015
We identified an Actinoallomurus strain producing NAI-107, a chlorinated lantibiotic effective against multidrug-resistant Gram… Expand
Highly Cited
2014
Highly Cited
2014
Background: NAI-107 is a potent lantibiotic with an unknown mode of action. Results: NAI-107 targets bactoprenol-bound cell… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2014
2014
NAI-107, a lantibiotic produced by Microbispora sp. 107891, shows potent activity against multi-drug-resistant bacterial… Expand
2014
2014
ABSTRACT NAI-107 is a novel lantibiotic compound with potent in vitro activity against Gram-positive bacteria, including… Expand
  • table 1
  • table 2
2012
2012
Lantibiotics 97518 and NAI‐107, produced by the related genera Planomonospora and Microbispora respectively, are members of a… Expand
Highly Cited
2011
Highly Cited
2011
ABSTRACT NAI-107 is a novel lantibiotic active against Gram-positive bacteria, including methicillin-resistant Staphylococcus… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 4